ABORDĂRI PSIHOFARMACOLOGICE ALE MANIFESTĂRILOR AFECTIVE DIN CADRUL SCHIZOFRENIEI

October 1, 2000

D. Vasile *, Emilia Lunguț **
* Dr. D. Vasile – medic primar psihiatrie SCMC
** Dr. Emilia Lungu – medic primar neurolog SCMC

Abstract

The most frequent complication in the course of schizophrenia is depression which is very difficult to differentiate from neuroleptic – induced depressions. Two therapeutic options were studied in the treatment of this kind of depression: TCA’s (lmipramine, Amitryptiline) and selective serotonine – recapture inhibitors (Fluoxetine). Fluoxetine, due to its pharmacodynamic actions, is the first choice antidepressant agent in the treatment of depressive mood to schizophrenic patients.

Previous article in this issue

ACTUALITĂȚI ÎN PROFILAXIA INFECȚIILOR DETERMINATE DE HERPESVIRUSURI CU FOCAR DE LATENȚĂ NEURAL

Next article in this issue

TRATAMENTUL SPASMELOR INFANTILE